Is induction chemotherapy the new standard in organ preservation treatment for locally advanced head and neck cancer in 2010?

Editorial

Sandro V Porceddu. Asia Pac J Clin Oncol. 2010 Jun.

. 2010 Jun;6(2):75-6.

doi: 10.1111/j.1743-7563.2010.01294.x.

No abstract available

Similar articles

Effectiveness of salvage neck dissection for advanced regional metastases when induction chemotherapy and radiation are used for organ preservation.
Wolf GT, Fisher SG. Wolf GT, et al. Laryngoscope. 1992 Aug;102(8):934-9. doi: 10.1288/00005537-199208000-00015. Laryngoscope. 1992. PMID: 1495357 Clinical Trial.
[Role of neoadjuvant chemotherapy for management of resectable head and neck cancer].
Horiuchi M, Tamura Y, Miyake H. Horiuchi M, et al. Gan To Kagaku Ryoho. 1994 Mar;21(4):417-24. Gan To Kagaku Ryoho. 1994. PMID: 8129381 Review. Japanese.
The role of chemotherapy in the curative treatment of head and neck cancer.
Pfister DG, Shaha AR, Harrison LB. Pfister DG, et al. Surg Oncol Clin N Am. 1997 Oct;6(4):749-68. Surg Oncol Clin N Am. 1997. PMID: 9309092 Review.
Induction chemotherapy in the management of squamous cell carcinoma of the head and neck.
Roman E, Raez LE, Santos ES. Roman E, et al. Expert Rev Anticancer Ther. 2006 Sep;6(9):1205-15. doi: 10.1586/14737140.6.9.1205. Expert Rev Anticancer Ther. 2006. PMID: 17020455 Review.
Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
Chang PM, Chen PM, Chu PY, Wang LW, Tai SK, Tsai TL, Huang JL, Wang YF, Chang SY, Yang MH. Chang PM, et al. Cancer Chemother Pharmacol. 2008 Dec;63(1):9-17. doi: 10.1007/s00280-008-0702-1. Epub 2008 Mar 15. Cancer Chemother Pharmacol. 2008. PMID: 18343925 Clinical Trial.